GILD Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | Parsey Merdad | officer: Chief Medical Officer | 96,304 | S-Sale | D | 2,000 | 72.96 | 145,920.00 |
| 2024-03-28 | Lofton Kevin E | director | 3,258.1388 | A-Award | A | 33.8931 | 0.00 | 0.00 |
| 2024-03-10 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 54,980 | A-Award | A | 54,980 | 75.12 | 4,130,098.00 |
| 2024-03-10 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 40,083 | A-Award | A | 10,815 | 0.00 | 0.00 |
| 2024-03-10 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 29,268 | M-Exempt | D | 2,555 | 0.00 | 0.00 |
| 2024-03-10 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 14,603 | M-Exempt | A | 2,555 | 0.00 | 0.00 |
| 2024-03-10 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 13,757 | F-InKind | D | 846 | 75.12 | 63,552.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 33,422 | M-Exempt | A | 1,934 | 0.00 | 0.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 32,632 | F-InKind | D | 790 | 75.12 | 59,345.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 31,488 | M-Exempt | A | 748 | 0.00 | 0.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 18,663 | A-Award | A | 4,825 | 0.00 | 0.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 15,772 | M-Exempt | D | 748 | 0.00 | 0.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 13,838 | M-Exempt | D | 1,934 | 0.00 | 0.00 |
| 2024-03-10 | Patterson Sandra | officer: SVP, Controllership | 13,660 | A-Award | A | 13,660 | 75.12 | 1,026,139.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 103,107 | M-Exempt | A | 6,946 | 0.00 | 0.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 98,304 | F-InKind | D | 4,803 | 75.12 | 360,801.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 96,161 | M-Exempt | A | 3,455 | 0.00 | 0.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 89,660 | A-Award | A | 89,660 | 75.12 | 6,735,259.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 48,214 | A-Award | A | 17,640 | 0.00 | 0.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 37,520 | M-Exempt | D | 3,455 | 0.00 | 0.00 |
| 2024-03-10 | Parsey Merdad | officer: Chief Medical Officer | 30,574 | M-Exempt | D | 6,946 | 0.00 | 0.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 498,629 | M-Exempt | A | 19,140 | 0.00 | 0.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 484,847 | F-InKind | D | 13,782 | 75.12 | 1,035,304.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 479,489 | M-Exempt | A | 10,800 | 0.00 | 0.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 279,130 | A-Award | A | 279,130 | 75.12 | 20,968,246.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 135,862 | A-Award | A | 54,910 | 0.00 | 0.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 100,092 | M-Exempt | D | 10,800 | 0.00 | 0.00 |
| 2024-03-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 80,952 | M-Exempt | D | 19,140 | 0.00 | 0.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 122,991 | M-Exempt | A | 6,819 | 0.00 | 0.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 118,432 | F-InKind | D | 4,559 | 75.12 | 342,472.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 116,172 | M-Exempt | A | 3,025 | 0.00 | 0.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 87,970 | A-Award | A | 87,970 | 75.12 | 6,608,306.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 47,448 | A-Award | A | 17,305 | 0.00 | 0.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 36,962 | M-Exempt | D | 3,025 | 0.00 | 0.00 |
| 2024-03-10 | Mercier Johanna | officer: Chief Commercial Officer | 30,143 | M-Exempt | D | 6,819 | 0.00 | 0.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 139,488 | M-Exempt | A | 6,707 | 0.00 | 0.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 134,983 | F-InKind | D | 4,505 | 75.12 | 338,416.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 132,781 | M-Exempt | A | 3,025 | 0.00 | 0.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 87,970 | A-Award | A | 87,970 | 75.12 | 6,608,306.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 46,407 | A-Award | A | 17,305 | 0.00 | 0.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 35,040 | M-Exempt | D | 3,025 | 0.00 | 0.00 |
| 2024-03-10 | Dickinson Andrew D | officer: Chief Financial Officer | 28,333 | M-Exempt | D | 6,707 | 0.00 | 0.00 |
| 2024-02-28 | Parsey Merdad | officer: Chief Medical Officer | 100,936 | S-Sale | D | 2,000 | 73.18 | 146,360.00 |
| 2024-02-29 | Parsey Merdad | officer: Chief Medical Officer | 92,706 | S-Sale | D | 8,230 | 72.74 | 598,624.00 |
| 2024-02-02 | LOVE TED W | director | 2,996 | A-Award | A | 2,996 | 76.96 | 230,572.00 |
| 2024-02-02 | LOVE TED W | director | 512 | A-Award | A | 512 | 0.00 | 0.00 |
| 2024-02-01 | LOVE TED W | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2024-01-31 | Parsey Merdad | officer: Chief Medical Officer | 126,325 | A-Award | A | 56,624 | 0.00 | 0.00 |
| 2024-01-31 | Parsey Merdad | officer: Chief Medical Officer | 102,616 | F-InKind | D | 23,709 | 78.26 | 1,855,466.00 |
| 2024-01-31 | Parsey Merdad | officer: Chief Medical Officer | 69,701 | A-Award | A | 20,229 | 0.00 | 0.00 |
| 2024-01-31 | Mercier Johanna | officer: Chief Commercial Officer | 135,656 | A-Award | A | 53,969 | 0.00 | 0.00 |
| 2024-01-31 | Mercier Johanna | officer: Chief Commercial Officer | 113,147 | F-InKind | D | 22,509 | 78.26 | 1,761,554.00 |
| 2024-01-31 | Mercier Johanna | officer: Chief Commercial Officer | 81,687 | A-Award | A | 20,086 | 0.00 | 0.00 |
| 2024-01-31 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 11,728 | A-Award | A | 4,646 | 0.00 | 0.00 |
| 2024-01-31 | Dickinson Andrew D | officer: Chief Financial Officer | 152,846 | A-Award | A | 55,955 | 0.00 | 0.00 |
| 2024-01-31 | Dickinson Andrew D | officer: Chief Financial Officer | 129,436 | F-InKind | D | 23,410 | 78.26 | 1,832,067.00 |
| 2024-01-31 | Dickinson Andrew D | officer: Chief Financial Officer | 96,891 | A-Award | A | 19,006 | 0.00 | 0.00 |
| 2024-01-31 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 548,024 | A-Award | A | 179,877 | 0.00 | 0.00 |
| 2024-01-31 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 468,689 | F-InKind | D | 79,335 | 78.26 | 6,208,757.00 |
| 2024-01-31 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 368,147 | A-Award | A | 50,870 | 0.00 | 0.00 |
| 2024-01-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 31,823 | M-Exempt | D | 514 | 0.00 | 0.00 |
| 2024-01-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 7,276 | M-Exempt | A | 514 | 0.00 | 0.00 |
| 2024-01-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 7,082 | F-InKind | D | 194 | 80.23 | 15,565.00 |
| 2024-01-16 | Dickinson Andrew D | officer: Chief Financial Officer | 101,534 | S-Sale | D | 5,000 | 85.78 | 428,900.00 |
| 2024-01-09 | Mercier Johanna | officer: Chief Commercial Officer | 82,729 | S-Sale | D | 8,242 | 85.23 | 702,466.00 |
| 2023-12-28 | Lofton Kevin E | director | 3,224.2457 | A-Award | A | 29.5297 | 0.00 | 0.00 |
| 2023-12-10 | Mercier Johanna | officer: Chief Commercial Officer | 92,218 | M-Exempt | A | 2,730 | 0.00 | 0.00 |
| 2023-12-10 | Mercier Johanna | officer: Chief Commercial Officer | 90,971 | F-InKind | D | 1,247 | 79.02 | 98,538.00 |
| 2023-12-10 | Mercier Johanna | officer: Chief Commercial Officer | 39,987 | M-Exempt | D | 2,730 | 0.00 | 0.00 |
| 2023-12-10 | Parsey Merdad | officer: Chief Medical Officer | 72,909 | M-Exempt | A | 2,779 | 0.00 | 0.00 |
| 2023-12-10 | Parsey Merdad | officer: Chief Medical Officer | 71,640 | F-InKind | D | 1,269 | 79.02 | 100,276.00 |
| 2023-12-10 | Parsey Merdad | officer: Chief Medical Officer | 40,975 | M-Exempt | D | 2,779 | 0.00 | 0.00 |
| 2023-12-10 | Patterson Sandra | officer: SVP, Controllership | 30,642 | M-Exempt | A | 518 | 0.00 | 0.00 |
| 2023-12-10 | Patterson Sandra | officer: SVP, Controllership | 30,420 | F-InKind | D | 222 | 79.02 | 17,542.00 |
| 2023-12-10 | Patterson Sandra | officer: SVP, Controllership | 16,520 | M-Exempt | D | 518 | 0.00 | 0.00 |
| 2023-12-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 391,032 | M-Exempt | A | 7,347 | 0.00 | 0.00 |
| 2023-12-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 387,691 | F-InKind | D | 3,341 | 79.02 | 264,006.00 |
| 2023-12-10 | O'Day Daniel Patrick | director, officer: Chairman & CEO | 110,892 | M-Exempt | D | 7,347 | 0.00 | 0.00 |
| 2023-12-10 | Dickinson Andrew D | officer: Chief Financial Officer | 107,728 | M-Exempt | A | 2,617 | 0.00 | 0.00 |
| 2023-12-10 | Dickinson Andrew D | officer: Chief Financial Officer | 106,534 | F-InKind | D | 1,194 | 79.02 | 94,350.00 |
| 2023-12-10 | Dickinson Andrew D | officer: Chief Financial Officer | 38,834 | M-Exempt | D | 2,617 | 0.00 | 0.00 |
| 2023-11-10 | Dickinson Andrew D | officer: Chief Financial Officer | 105,915 | M-Exempt | A | 1,912 | 0.00 | 0.00 |
| 2023-11-10 | Dickinson Andrew D | officer: Chief Financial Officer | 105,111 | F-InKind | D | 804 | 75.92 | 61,040.00 |
| 2023-11-10 | Dickinson Andrew D | officer: Chief Financial Officer | 41,451 | M-Exempt | D | 1,912 | 0.00 | 0.00 |
| 2023-10-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 32,337 | M-Exempt | D | 514 | 0.00 | 0.00 |
| 2023-10-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 7,005 | M-Exempt | A | 514 | 0.00 | 0.00 |
| 2023-10-25 | Telman Deborah H | officer: EVP, Corporate Affairs & GC | 6,762 | F-InKind | D | 243 | 78.39 | 19,049.00 |
| 2023-10-17 | Dickinson Andrew D | officer: Chief Financial Officer | 104,003 | S-Sale | D | 5,000 | 80.00 | 400,017.00 |
| 2023-09-28 | Lofton Kevin E | director | 3,194.7161 | A-Award | A | 31.4564 | 0.00 | 0.00 |
| 2023-09-12 | Parsey Merdad | officer: Chief Medical Officer | 70,130 | S-Sale | D | 1,501 | 76.99 | 115,562.00 |
| 2023-09-10 | Mercier Johanna | officer: Chief Commercial Officer | 90,744 | M-Exempt | A | 2,730 | 0.00 | 0.00 |
| 2023-09-10 | Mercier Johanna | officer: Chief Commercial Officer | 89,488 | F-InKind | D | 1,256 | 76.00 | 95,456.00 |
| 2023-09-10 | Mercier Johanna | officer: Chief Commercial Officer | 42,717 | M-Exempt | D | 2,730 | 0.00 | 0.00 |
| 2023-09-10 | Dickinson Andrew D | officer: Chief Financial Officer | 110,206 | M-Exempt | A | 2,619 | 0.00 | 0.00 |
| 2023-09-10 | Dickinson Andrew D | officer: Chief Financial Officer | 109,003 | F-InKind | D | 1,203 | 76.00 | 91,428.00 |
| 2023-09-10 | Dickinson Andrew D | officer: Chief Financial Officer | 43,363 | M-Exempt | D | 2,619 | 0.00 | 0.00 |
| 2023-09-10 | Patterson Sandra | officer: SVP, Controllership | 30,273 | M-Exempt | A | 519 | 0.00 | 0.00 |
| 2023-09-10 | Patterson Sandra | officer: SVP, Controllership | 30,124 | F-InKind | D | 149 | 76.00 | 11,324.00 |
| 2023-09-10 | Patterson Sandra | officer: SVP, Controllership | 17,038 | M-Exempt | D | 519 | 0.00 | 0.00 |
| 2023-09-10 | Parsey Merdad | officer: Chief Medical Officer | 72,909 | M-Exempt | A | 2,779 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
